Search Results 761-770 of 17079 for egfr

1. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

   Estimated creatinine clearance (i.e., estimated glomerular filtration rate [eGFR] using Cockcroft-Gault) ≥ 30 mL/min. Able to receive all outpatient ...

2. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

   The key outcomes in the study focus on evaluation of clinical remission, defined as Birmingham Vasculitis Activity Score (BVAS)=0 with a corticosteroid dose of ...

3. YA-101 in Subjects with Multiple System Atrophy - Mayo Clinic

   Evidence of renal impairment at screening, as indicated by an estimated glomerular filtration rate (eGFR) of 1.5 mg/dl. Subjects with hepatic impairment, as ...

4. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Serum creatinine of ≤1.5 x upper limit of normal (ULN), OR estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 Hepatic function defined as: ...

5. Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 - Mayo Clinic

   - Estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2, using the modification of diet in renal disease (MDRD) equation - Serum lipase ≤1.5 ...

6. Focal segmental glomerulosclerosis (FSGS) - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

7. A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites - Mayo Clinic

   Serum bilirubin > 5 mg/dl; eGFR < 30 ml/min/1.73m2 by MDRD (Modification of Diet in Renal Disease) method; Gastrointestinal hemorrhage due to portal ...

8. GMCI Plus Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC - Mayo Clinic

   Patients with known EGFR mutation, ALK fusion, or ROS1 fusion positive NSCLC, or that are receiving tyrosine kinase inhibitor (TKI) agents/ALK/ROS1 ...

9. A Study Of Treatment For Medulloblastoma Using Sodium Thiosulfate To Reduce Hearing Loss - Mayo Clinic

   Note: Estimated GFR (eGFR) from serum creatinine, cystatin C or other estimates are not acceptable for determining eligibility. Total bilirubin =< 1.5 x ...

10. Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery - Mayo Clinic

    eGFR ≤20 mL/min/1.73m2 or need for dialysis. Surgery for aortic dissection or to correct a major congenital heart defect. Administration of iodinated ...